In the media: Genomeweb: Partial reimbursement for comprehensive DNA test in the Netherlands
This week, Genomeweb’s Precision Oncology News brought the news that the Dutch House of Representatives has recently unanimously decided to reimburse the comprehensive DNA testing for certain patient groups.
Read the article.
More information about the comprehensive DNA test.
You read an article in the category Billing code. You may also be interested in OncoAct.All news
Also read
Screening for T cells that already fight the tumor: Hartwig’s pipeline in practice
By Laura Nederveen In the search for more effective cancer treatments, Alena Gros and her team at Vall d’Hebron Institute …
Healthcare providers share insights about GENAYA for young adult cancer patients
In a series of short videos, our specialists share their insights on the GENAYA project. They explain what GENAYA is, …
Single WGS analysis of metastases is sufficient in most cases
DNA analysis of the tumor is of crucial importance to determine treatment options for patients with metastasized lung cancer. But …
I know how important knowledge of hereditary predisposition to cancer can be. This is why I think it is so important that comprehensive patient reports include precisely that carrier information, if the patient wishes to be informed of it.